arrow
A

Angela Santoro

fondazione policlinico universitario agostino gemelli irccs
H指数:38
被引数:4,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic significance of lymphovascular space invasion extent across molecular classes in early-stage endometrial cancer: a large retrospective analysis.

早期子宫内膜癌中淋巴血管间隙浸润程度在分子类别中的预后意义:一项大规模回顾性分析

2026-05-300
OAAI
Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer

LAR+三阴性乳腺癌肿瘤免疫微环境的空间组织

2026-05-220
OAAI
Interplay Between HER2-Low Status, Hormone Receptor Expression, and Therapeutic Response to Cyclin-Dependent Kinase 4/6 Inhibitors as First-Line Treatment in Luminal-like Metastatic Breast Cancer: The CYCLHER Study

ER2低表达状态、激素受体表达与细胞周期蛋白依赖性激酶4/6抑制剂作为luminal样转移性乳腺癌一线治疗的疗效反应的相互作用:CYCLHER研究

2026-05-190
OAAI
Focal lymphovascular space invasion: friend or foe? A large retrospective analysis on stage I endometrioid endometrial carcinomas

病灶淋巴血管间隙浸润:益友还是祸患?一项关于Ⅰ期子宫内膜样子宫内膜癌的大规模回顾性分析

2025-08-200
PREAI
Inverse Regulation of TLR4 and PD-L1 Shapes the Inflammatory Tumor Microenvironment in Oral Squamous Cell Carcinomas

TLR4和PD-L1的负向调控塑造了口腔鳞状细胞癌的炎症性肿瘤微环境

2025-08-050
OA
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors)

乳腺癌肉瘤和恶性叶状肿瘤的长期预后:BEAM∗研究组的20年观察性分析。(∗乳腺癌肉瘤欧洲协会)

2025-07-080
OA
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study

新辅助治疗后乳腺癌复发的预测风险因素:NEORISK研究

2025-06-140
PRE
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors

乳腺恶性间叶组织肿瘤:原发性肉瘤和恶性分叶状肿瘤的当前挑战与新展望

2025-04-200
OA